Literature DB >> 7700968

Dexamethasone induced enhanced enkephalin degradation by angiotensin-converting enzyme (ACE) of endothelial cells.

M F Melzig1, G Heder.   

Abstract

The Leu-enkephalin breakdown by ectopeptidases of cultivated endothelial cells is increased in a concentration-dependent manner by dexamethasone treatment. This glucocorticoid induced selectively the angiotensin-converting enzyme (ACE) of the cells. The activity of the closely related enzyme neutral metalloenopeptidase (NEP) and the aminopeptidase N (APN) also present on the endothelial cell surface were not affected or slightly decreased by dexamethasone. The data indicate the significance of ACE for degradation of Leu-enkephalin during the stress reaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7700968

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  The Pharmacogenetic Footprint of ACE Inhibition: A Population-Based Metabolomics Study.

Authors:  Elisabeth Altmaier; Cristina Menni; Margit Heier; Christa Meisinger; Barbara Thorand; Jan Quell; Michael Kobl; Werner Römisch-Margl; Ana M Valdes; Massimo Mangino; Melanie Waldenberger; Konstantin Strauch; Thomas Illig; Jerzy Adamski; Tim Spector; Christian Gieger; Karsten Suhre; Gabi Kastenmüller
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.